Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
JAMA Network Open · 12.11.2026 · 9 (11) · e2643842
DOI: 10.1001/jamanetworkopen.2026.43842 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 12.11.2026. Verfasst von Michihiko Goto. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City.
- Center for Access & Delivery Research and Evaluation (CADRE), Iowa City VA Health Care System, Iowa City, Iowa.
Zitieren
APA
Goto, M. (2026). Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence. JAMA Network Open, 9(11), e2643842. https://doi.org/10.1001/jamanetworkopen.2026.43842
Vancouver
Goto M. Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence. JAMA Network Open. 2026;9(11):e2643842. doi:10.1001/jamanetworkopen.2026.43842
BibTeX
@article{Goto2026,
author = {Goto, Michihiko},
title = {Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {11},
pages = {e2643842},
doi = {10.1001/jamanetworkopen.2026.43842}
}
EUVIMED